Guided Therapeutics, Inc. (GTHP)
OTCMKTS: GTHP · Delayed Price · USD
0.117
-0.006 (-4.53%)
Mar 27, 2024, 2:48 PM EDT - Market closed
Company Description
Guided Therapeutics, Inc., a medical technology company, focuses on developing medical devices.
It focuses on the commercialization of LuViva, a non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected and fluorescent light.
The company was formerly known as SpectRx, Inc. and changed its name to Guided Therapeutics, Inc. in February 2008.
Guided Therapeutics, Inc. was incorporated in 1992 and is based in Norcross, Georgia.
Guided Therapeutics, Inc.
Country | United States |
Founded | 1992 |
IPO Date | Jul 1, 1997 |
Industry | Medical Devices |
Sector | Healthcare |
Employees | 6 |
CEO | Dr. Mark L. Faupel Ph.D. |
Contact Details
Address: 5835 Peachtree Corners East, Suite B Peachtree Corners, Georgia 30092 United States | |
Phone | (770) 242-8723 |
Website | guidedinc.com |
Stock Details
Ticker Symbol | GTHP |
Exchange | OTCMKTS |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0000924515 |
CUSIP Number | 40171F501 |
ISIN Number | US40171F5017 |
Employer ID | 58-2029543 |
SIC Code | 3845 |
Key Executives
Name | Position |
---|---|
Dr. Gene S. Cartwright Ph.D. | Chief Executive Officer, President, Acting Chief Financial Officer and Director |
Dr. Mark L. Faupel Ph.D. | Chief Operating Officer, Secretary and Director |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Feb 20, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
Feb 14, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
Nov 13, 2023 | 10-Q | Quarterly Report |
Aug 10, 2023 | 10-Q | Quarterly Report |
May 15, 2023 | 10-Q | Quarterly Report |
Mar 30, 2023 | 10-K | Annual Report |
Mar 9, 2023 | 8-K | Current Report |
Feb 14, 2023 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
Jan 25, 2023 | EFFECT | Notice of Effectiveness |
Jan 13, 2023 | S-1 | General form for registration of securities under the Securities Act of 1933 |